Rita A Karachun Net Worth & Insider Trades
Rita A Karachun - Sr. VP Fince-Global Controller, Merck & Co, Inc.
What is Rita A Karachun's Net Worth?
The current estimated net worth of Merck & Co, Inc.'s Sr. VP Fince-Global Controller, Rita A Karachun, is estimated to be about $15.73M . Rita A Karachun owns about 16,175 units of Merck & Co, Inc. common stock. In the last 5 years at Merck & Co, Inc., Rita A Karachun has sold an estimated value of $6.16M worth.
What is Rita A Karachun's Past Insider Trading?
Rita A Karachun's largest purchase order was 64,662 units , worth over $3.83M on February 14, 2019. Rita A Karachun's largest sale order was 64,662 units , worth over $5.11M on February 14, 2019. In total, Rita A Karachun has made about 16 transactions over 5 years of their time at Merck & Co, Inc.. Rita A Karachun usually trades in May, with the busiest year in 2018 and 2019.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Rita Karachun
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Rita A Karachun's' Mailing Address?
- Mailing address is 2000 Galloping Hill Road Kenilworth NJ 07033 NJ
Merck & Co, Inc. Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Change in Pension Value
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|---|
| Kenneth C. Frazier | 2020 | $1,702,006 | $0 | $10,778,499 | $4,724,098 | $2,218,500 | $2,288,641 | $376,685 | $22,088,429 |
| Kenneth C. Frazier | 2019 | $1,659,482 | $0 | $11,425,398 | $4,500,763 | $4,609,200 | $5,078,147 | $375,485 | $27,648,475 |
| Kenneth C. Frazier | 2018 | $1,610,577 | $0 | $9,456,006 | $3,901,093 | $3,061,800 | $0 | $2,905,028 | $20,934,504 |
| Robert M. Davis | 2020 | $1,112,795 | $0 | $2,737,406 | $1,199,772 | $1,018,194 | $611,948 | $159,395 | $6,839,510 |
| Robert M. Davis | 2019 | $1,075,557 | $0 | $3,046,785 | $1,200,201 | $2,090,702 | $193,079 | $120,864 | $7,727,188 |
| Robert M. Davis | 2018 | $1,043,726 | $0 | $2,764,058 | $1,140,317 | $1,389,977 | $171,067 | $111,695 | $6,620,840 |
| Sanat Chattopadhyay | 2020 | $805,046 | $0 | $1,916,154 | $839,840 | $645,975 | $631,561 | $107,579 | $4,946,155 |
| Sanat Chattopadhyay | 2019 | $719,467 | $0 | $1,751,906 | $690,121 | $1,200,352 | $963,252 | $93,495 | $5,418,593 |
| Sanat Chattopadhyay | 2018 | - | - | - | - | - | - | - | - |
| Roger M. Perlmutter, | 2020 | $1,191,660 | $0 | $3,421,758 | $1,499,718 | $1,090,355 | $447,007 | $173,570 | $7,824,068 |
| Roger M. Perlmutter, | 2019 | $1,151,783 | $0 | $3,808,436 | $1,500,254 | $2,238,873 | $361,579 | $162,429 | $9,223,354 |
| Roger M. Perlmutter, | 2018 | $1,116,262 | $0 | $2,909,523 | $1,200,341 | $1,488,486 | $236,334 | $147,696 | $7,098,642 |
| Jennifer Zachary | 2020 | $913,101 | $0 | $1,710,879 | $749,854 | $759,347 | $302,743 | $121,231 | $4,557,155 |
| Jennifer Zachary | 2019 | $856,818 | $0 | $1,790,006 | $705,120 | $1,529,500 | $83,704 | $80,572 | $5,045,720 |
| Jennifer Zachary | 2018 | $553,846 | $750,000 | $2,454,748 | $600,166 | $638,400 | $30,462 | $165,997 | $5,193,619 |
| No matching records found | |||||||||
Source: https://www.sec.gov/Archives/edgar/data/310158/000119312521106317/d50486ddef14a.htm
What are Merck & Co, Inc.'s Past Insider Trades?
Merck & Co, Inc.'s most recent insider trade came on August 15, 2023 by Steven Mizell who sold 4,250 units worth $463.29K . In the last 12 years, insiders at Merck & Co, Inc. have sold an estimated value of $1.02B and bought an estimated value of $484.02M worth of shares. Insider trading is most common in May, with the busiest year in 2010. The most active traders at the company are Peter C Wendell, Director, Kenneth C Frazier, Executive Chair, and Wendell P Weeks, Director .
Merck & Co., Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||